In addition, GLP-treatment reversed the levels of fasting plasma lipids, hepatic lipid accumulation, and higher blood glucose levels (Li et al., 2020), increased SOD, CAT, and GSH-Px expression, as well as promoted Nrf2 and HO-1expression in db/db mice, by contrast, the content of MDA and TNF-a decreased in these mice
This means that using them together could lead to unexpected reactions in the body, such as feeling unusually sleepy, experiencing dizziness, or having changes in appetite or mood
Stratified effect sizes for changes in time in range, HbA1c and weight loss are listed according to category of baseline BMI
Variations in glucose levels, vascular impairment, chronic inflammation, and oxidative stress foster an environment that disrupts neurotransmitter function, ultimately influencing mood regulation